The relationship between uncertainty and fear of disease progression among newly diagnosed cancer patients: the mediating role of intolerance of uncertainty.
Fear of Disease Progression
Intolerance of uncertainty
Newly diagnosed Cancer
Uncertainty in illness
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
31 Oct 2024
31 Oct 2024
Historique:
received:
14
06
2024
accepted:
21
10
2024
medline:
1
11
2024
pubmed:
1
11
2024
entrez:
1
11
2024
Statut:
epublish
Résumé
One of the most prevalent unmet needs among cancer patients is the fear of disease progression (FoP). This cross-sectional study aimed to identify the relationships among uncertainty in illness (UI), intolerance of uncertainty (IU), and FoP among newly diagnosed cancer patients and to verify the mediating role of IU in the relationship between UI and FoP. A total of 202 newly diagnosed cancer patients (male: 105, 51.98%; mean age: 47.45 ± 14.8 years; lung cancer: 49, 24.26%) were recruited by convenience sampling. The patients completed a homemade questionnaire that assessed demographic characteristics, the Fear of Progression Questionnaire-Short Form, the Mishel Uncertainty in Illness Scale, and the Intolerance of Uncertainty Scale. The prevalence of FoP among newly diagnosed cancer patients was 87.62%, and the prevalences of high, medium, and low levels of UI were 15.84%, 73.27%, and 10.89%, respectively. The mean score on the Intolerance of Uncertainty Scale was 41.19 ± 10.11. FoP among newly diagnosed cancer patients was positively correlated with UI (r = 0.656, P < 0.001) and IU (r = 0.711, P < 0.001). Moreover, IU was positively correlated with UI (r = 0.634, P < 0.001). IU partially mediated the effect of UI on FoP, accounting for 47.60% of the total effect. Newly diagnosed cancer patients have a high prevalence of FoP. UI can directly or indirectly affect FoP through the mediating role of IU. Healthcare professionals can help newly diagnosed cancer patients mitigate their FoP by reducing IU in light of UI.
Sections du résumé
BACKGROUND
BACKGROUND
One of the most prevalent unmet needs among cancer patients is the fear of disease progression (FoP). This cross-sectional study aimed to identify the relationships among uncertainty in illness (UI), intolerance of uncertainty (IU), and FoP among newly diagnosed cancer patients and to verify the mediating role of IU in the relationship between UI and FoP.
METHODS
METHODS
A total of 202 newly diagnosed cancer patients (male: 105, 51.98%; mean age: 47.45 ± 14.8 years; lung cancer: 49, 24.26%) were recruited by convenience sampling. The patients completed a homemade questionnaire that assessed demographic characteristics, the Fear of Progression Questionnaire-Short Form, the Mishel Uncertainty in Illness Scale, and the Intolerance of Uncertainty Scale.
RESULTS
RESULTS
The prevalence of FoP among newly diagnosed cancer patients was 87.62%, and the prevalences of high, medium, and low levels of UI were 15.84%, 73.27%, and 10.89%, respectively. The mean score on the Intolerance of Uncertainty Scale was 41.19 ± 10.11. FoP among newly diagnosed cancer patients was positively correlated with UI (r = 0.656, P < 0.001) and IU (r = 0.711, P < 0.001). Moreover, IU was positively correlated with UI (r = 0.634, P < 0.001). IU partially mediated the effect of UI on FoP, accounting for 47.60% of the total effect.
CONCLUSIONS
CONCLUSIONS
Newly diagnosed cancer patients have a high prevalence of FoP. UI can directly or indirectly affect FoP through the mediating role of IU. Healthcare professionals can help newly diagnosed cancer patients mitigate their FoP by reducing IU in light of UI.
Identifiants
pubmed: 39482640
doi: 10.1186/s12888-024-06201-4
pii: 10.1186/s12888-024-06201-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
756Subventions
Organisme : the Natural Science Foundation of Hunan Province
ID : 2023JJ40884
Organisme : the General project of Hunan Health Commission
ID : B202314018897
Organisme : the China Scholarship Council program
ID : [2023]54
Informations de copyright
© 2024. The Author(s).
Références
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660
doi: 10.3322/caac.21660
pubmed: 33538338
Zheng R, Zhang S, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2016. J Natl Cancer Cent. 2022;2(1):1–9. https://doi.org/10.1016/j.jncc.2022.02.002
doi: 10.1016/j.jncc.2022.02.002
pubmed: 39035212
pmcid: 11256658
Ghoshal S, Miriyala R, Elangovan A, Rai B. Why newly diagnosed Cancer patients require supportive care? An audit from a Regional Cancer Center in India. Indian J Palliat Care. 2016;22(3):326–30. https://doi.org/10.4103/0973-1075.185049
doi: 10.4103/0973-1075.185049
pubmed: 27559263
pmcid: 4973495
Boyes AW, Girgis A, D’Este CA, Zucca AC, Lecathelinais C, Carey ML. Prevalence and predictors of the short-term trajectory of anxiety and depression in the first year after a cancer diagnosis: a population-based longitudinal study. J Clin Oncol. 2013;31(21):2724–9. https://doi.org/10.1200/JCO.2012.44.7540
doi: 10.1200/JCO.2012.44.7540
pubmed: 23775970
Dankert A, Duran G, Engst-Hastreiter U, Keller M, Waadt S, Henrich G, et al. Fear of progression in patients with cancer, diabetes mellitus and chronic arthritis. Rehabilitation (Stuttg). 2003;42(3):155–63. https://doi.org/10.1055/s-2003-40094
doi: 10.1055/s-2003-40094
pubmed: 12813652
Ocalewski J, Michalska P, Izdebski P, Jankowski M, Zegarski W. Fear of Cancer Progression and Health Behaviors in patients with colorectal Cancer. Am J Health Behav. 2021;45(1):138–51. https://doi.org/10.5993/AJHB.45.1.11
doi: 10.5993/AJHB.45.1.11
pubmed: 33402244
Su CH, Liu Y, Hsu HT, Kao CC. Cancer fear, emotion regulation, and emotional distress in patients with newly diagnosed Lung Cancer. Cancer Nurs. 2024;47(1):56–63. https://doi.org/10.1097/NCC.0000000000001150
doi: 10.1097/NCC.0000000000001150
pubmed: 35984922
Dinkel A, Marten-Mittag B, Kremsreiter K. Association between Daily Worry, pathological worry, and fear of progression in patients with Cancer. Front Psychol. 2021;12:648623. https://doi.org/10.3389/fpsyg.2021.648623
doi: 10.3389/fpsyg.2021.648623
pubmed: 34456783
pmcid: 8384960
Hall DL, Lennes IT, Pirl WF, Friedman ER, Park ER. Fear of recurrence or progression as a link between somatic symptoms and perceived stress among cancer survivors. Support Care Cancer. 2017;25(5):1401–7. https://doi.org/10.1007/s00520-016-3533-3
doi: 10.1007/s00520-016-3533-3
pubmed: 27966025
Kuang X, Long F, Chen H, Huang Y, He L, Chen L, et al. Correlation research between fear of disease progression and quality of life in patients with lung cancer. Ann Palliat Med. 2022;11(1):35–44. https://doi.org/10.21037/apm-21-2821
doi: 10.21037/apm-21-2821
pubmed: 35144396
Lee I, Park C. The mediating effect of social support on uncertainty in illness and quality of life of female cancer survivors: a cross-sectional study. Health Qual Life Outcomes. 2020;18(1):143. https://doi.org/10.1186/s12955-020-01392-2
doi: 10.1186/s12955-020-01392-2
pubmed: 32429954
pmcid: 7236321
Vrinten C, Waller J, von Wagner C, Wardle J. Cancer fear: facilitator and deterrent to participation in colorectal cancer screening. Cancer Epidemiol Biomarkers Prev. 2015;24(2):400–5. https://doi.org/10.1158/1055-9965
doi: 10.1158/1055-9965
pubmed: 25634890
pmcid: 4338553
Yang Y, Li W, Wen Y, Wang H, Sun H, Liang W, et al. Fear of cancer recurrence in adolescent and young adult cancer survivors: a systematic review of the literature. Psychooncology. 2019;28(4):675–86. https://doi.org/10.1002/pon.5013
doi: 10.1002/pon.5013
pubmed: 30703261
Hall DL, Jimenez RB, Perez GK, Rabin J, Quain K, Yeh GY, et al. Fear of Cancer recurrence: a model examination of physical symptoms, emotional distress, and Health Behavior Change. J Oncol Pract. 2019;15(9):e787–97. https://doi.org/10.1200/JOP.18.00787
doi: 10.1200/JOP.18.00787
pubmed: 31298966
pmcid: 6743221
Mishel MH. Reconceptualization of the uncertainty in illness theory. Image J Nurs Sch. 1990;22(4):256–62. https://doi.org/10.1111/j.1547-5069.1990.tb00225.x
doi: 10.1111/j.1547-5069.1990.tb00225.x
pubmed: 2292449
Mishel MH. Uncertainty in illness. Image J Nurs Sch. 1988;20(4):225–32. https://doi.org/10.1111/j.1547-5069.1988.tb00082.x
doi: 10.1111/j.1547-5069.1988.tb00082.x
pubmed: 3203947
Mishel MH. The measurement of uncertainty in illness. Nurs Res. 1981;30(5):258–63.
doi: 10.1097/00006199-198109000-00002
pubmed: 6912987
Guo HT, Wang SS, Zhang CF, Zhang HJ, Wei MX, Wu Y, et al. Investigation of factors influencing the fear of Cancer recurrence in breast Cancer patients using structural equation modeling: a cross-sectional study. Int J Clin Pract. 2022;2022:2794408. https://doi.org/10.1155/2022/2794408
doi: 10.1155/2022/2794408
pubmed: 36545346
pmcid: 9747310
Ye CL, Xie XL, Luo ML, Huang LH, Xu XP. Correlation among the fear of Cancer recurrence, uncertainty in illness and social support in postoperative patients with breast Cancer. Nurs J Chin PLA. 2019;36(11):23–6. https://doi.org/10.3969/j.issn.1008-9993.2019.11.006
doi: 10.3969/j.issn.1008-9993.2019.11.006
Huntley C, Young B, Tudur Smith C, Jha V, Fisher P. Testing times: the association of intolerance of uncertainty and metacognitive beliefs to test anxiety in college students. BMC Psychol. 2022;10(1):6. https://doi.org/10.1186/s40359-021-00710-7
doi: 10.1186/s40359-021-00710-7
pubmed: 34986890
pmcid: 8729154
Dugas MJ, Gagnon F, Ladouceur R, Freeston MH. Generalized anxiety disorder: a preliminary test of a conceptual model. Behav Res Ther. 1998;36(2):215–26. https://doi.org/10.1016/s0005-7967(97)00070-3
doi: 10.1016/s0005-7967(97)00070-3
pubmed: 9613027
Hebert EA, Dugas MJ. Behavioral experiments for intolerance of uncertainty: challenging the unknown in the treatment of generalized anxiety disorder. Cogn Behav Pract. 2019;26(2):421–36. https://doi.org/10.1016/j.cbpra.2018.07.007
doi: 10.1016/j.cbpra.2018.07.007
Buhr K, Dugas MJ. The role of fear of anxiety and intolerance of uncertainty in worry: an experimental manipulation. Behav Res Ther. 2009;47(3):215–23. https://doi.org/10.1016/j.brat.2008.12.004
doi: 10.1016/j.brat.2008.12.004
pubmed: 19159867
Song J, Cho E, Cho IK, Lee D, Kim J, Kim H, et al. Mediating effect of intolerance of uncertainty and Cancer-related dysfunctional beliefs about sleep on psychological symptoms and fear of Progression among Cancer patients. Psychiatry Investig. 2023;20(10):912–20. https://doi.org/10.30773/pi.2023.0127
doi: 10.30773/pi.2023.0127
pubmed: 37899214
pmcid: 10620329
Yang Y, Gorka SM, Pennell ML, Weinhold K, Orchard T. Intolerance of uncertainty and cognition in breast Cancer survivors: the mediating role of anxiety. Cancers (Basel). 2023;15(12):3105. https://doi.org/10.3390/cancers
doi: 10.3390/10.3390/cancers
pubmed: 37370715
Mehnert A, Herschbach P, Berg P, Henrich G, Koch U. Fear of progression in breast cancer patients–validation of the short form of the fear of Progression Questionnaire (FoP-Q-SF). Z Psychosom Med Psychother. 2006;52(3):274–88. https://doi.org/10.13109/zptm.2006.52.3.274
doi: 10.13109/zptm.2006.52.3.274
pubmed: 17156600
Waroquier P, Delevallez F, Razavi D, Merckaert I. Psychological factors associated with clinical fear of cancer recurrence in breast cancer patients in the early survivorship period. Psychooncology. 2022;31(11):1877–85. https://doi.org/10.1002/pon.5976
doi: 10.1002/pon.5976
pubmed: 35674194
Lebel S, Maheu C, Tomei C, Bernstein LJ, Courbasson C, Ferguson S, et al. Towards the validation of a new, blended theoretical model of fear of cancer recurrence. Psychooncology. 2018;27(11):2594–601. https://doi.org/10.1002/pon.4880
doi: 10.1002/pon.4880
pubmed: 30180279
Tomei C, Lebel S, Maheu C, Lefebvre M, Harris C. Examining the preliminary efficacy of an intervention for fear of cancer recurrence in female cancer survivors: a randomized controlled clinical trial pilot study. Supportive Care Cancer. 2018;26(8):2751–62. https://doi.org/10.1007/s00520-018-4097-1
doi: 10.1007/s00520-018-4097-1
Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82. https://doi.org/10.1037/0022-3514.51.6.1173
doi: 10.1037/0022-3514.51.6.1173
pubmed: 3806354
Wu QY, Ye ZX, Li L, Liu PY. Reliability and validity of Chinese version of fear of Progression Questionnaire-Short Form for cancer patients. Chin J Nurs. 2015;50(12):1515–9. https://doi.org/10.3761/j.issn.0254-1769.2015.12.021
doi: 10.3761/j.issn.0254-1769.2015.12.021
Xu SL, Huang XL. Test of Chinese Version of Mishel’s illness uncertainty scale. J Nurs Res. 1996;4(1A):59–69. http://ir.fy.edu.tw/ir/handle/987654321/3428
Carleton RN, Norton MA, Asmundson GJ. Fearing the unknown: a short version of the intolerance of uncertainty scale. J Anxiety Disord. 2007;21(1):105–17. https://doi.org/10.1016/j.janxdis.2006.03.014
doi: 10.1016/j.janxdis.2006.03.014
pubmed: 16647833
Wu LJ, Wang JN, Qi XD. Validity and reliability of the intolerance of uncertainty Scale-12 in middle school students. Chin Mental Health J. 2016;30(9):700–5. https://doi.org/10.16128/j.cnki.1005-3611.2017.02.020
doi: 10.16128/j.cnki.1005-3611.2017.02.020
Hayes AF, Rockwood NJ. Regression-based statistical mediation and moderation analysis in clinical research: observations, recommendations, and implementation. Behav Res Ther. 2017;98:39–57. https://doi.org/10.1016/j.brat.2016.11.001
doi: 10.1016/j.brat.2016.11.001
pubmed: 27865431
Luo X, Li W, Yang Y, Humphris G, Zeng L, Zhang Z, et al. High fear of Cancer recurrence in Chinese newly diagnosed Cancer patients. Front Psychol. 2020;11:1287. https://doi.org/10.3389/fpsyg.2020.01287
doi: 10.3389/fpsyg.2020.01287
pubmed: 32581984
pmcid: 7296085
Chen R, Yang H, Zhang H, Chen J, Liu S, Wei L. Fear of progression among postoperative patients with newly diagnosed lung cancer: a cross-sectional survey in China. BMC Psychol. 2023;11(1):168. https://doi.org/10.1186/s40359-023-01211-5
doi: 10.1186/s40359-023-01211-5
pubmed: 37217966
pmcid: 10201766
Lu QR, Liu QY, Fang S, Ma YJ, Zhang BX, Li HH, et al. Relationship between fear of progression and symptom burden, disease factors and social/family factors in patients with stage-IV breast cancer in Shandong, China. Cancer Med. 2024;13(4):e6749. https://doi.org/10.1002/cam4.6749
doi: 10.1002/cam4.6749
pubmed: 38457242
pmcid: 10923048
Liu X, Zhong J, Ren J, Zhang JE. The formation of Stigma and its Social consequences on Chinese people Living with Lung Cancer: a qualitative study. Oncol nurs Forum. 2023;50(5):589–98. https://doi.org/10.1188/23.ONF.589-598
doi: 10.1188/23.ONF.589-598
pubmed: 37677761
Pradhan P, Sharpe L, Menzies RE. Towards a stepped care model for managing fear of Cancer recurrence or progression in Cancer survivors. Cancer Manag Res. 2021;13:8953–65.
doi: 10.2147/CMAR.S294114
pubmed: 34880676
Yu Z, Sun D, Sun J. Social Support and Fear of Cancer recurrence among Chinese breast Cancer survivors: the mediation role of illness uncertainty. Front Psychol. 2022;13:864129. https://doi.org/10.3389/fpsyg.2022.864129
doi: 10.3389/fpsyg.2022.864129
pubmed: 35369168
pmcid: 8966644
Hall DL, Mishel MH, Germino BB. Living with cancer-related uncertainty: associations with fatigue, insomnia, and affect in younger breast cancer survivors. Support Care Cancer. 2014;22(9):2489–95. https://doi.org/10.1007/s00520-014-2243-y
doi: 10.1007/s00520-014-2243-y
pubmed: 24728586
pmcid: 6375671
Langmuir T, Chu A, Sehabi G, Giguère L, Lamarche J, Boudjatat W, et al. A new landscape in illness uncertainty: a systematic review and thematic synthesis of the experience of uncertainty in patients with advanced cancer receiving immunotherapy or targeted therapy. Psychooncology. 2023;32(3):356–67. https://doi.org/10.1002/pon.6093
doi: 10.1002/pon.6093
pubmed: 36609833
Han PKJ, Gutheil C, Hutchinson RN, LaChance JA. Cause or Effect? The role of prognostic uncertainty in the fear of Cancer recurrence. Front Psychol. 2020;11:626038. https://doi.org/10.3389/fpsyg.2020.626038
doi: 10.3389/fpsyg.2020.626038
pubmed: 33519656
Carleton RN. The intolerance of uncertainty construct in the context of anxiety disorders: theoretical and practical perspectives. Expert Rev Neurother. 2012;12(8):937–47. https://doi.org/10.1586/ern.12.82
doi: 10.1586/ern.12.82
pubmed: 23002938
Sahib A, Chen J, Cárdenas D, Calear AL. Intolerance of uncertainty and emotion regulation: a meta-analytic and systematic review. Clin Psychol Rev. 2023;101:102270. https://doi.org/10.1016/j.cpr.2023.102270
doi: 10.1016/j.cpr.2023.102270
pubmed: 36965452
Shen ZY, Li CY, Shi SJ, Ruan CH. The mediating effect of illness perception and cognitive emotion regulation on the relationship between social constraints and fear of cancer recurrence among hematopoietic stem cell transplantation patient. J Nurs Sci. 2023;38(22):10–4. https://doi.org/10.3870/j.issn.1001-4152.2016.06.105
doi: 10.3870/j.issn.1001-4152.2016.06.105
Yao NS, Yang Y, Shu S, Yin XC. Influence of intolerance of uncertainty on emotional disturbance: mediating Effect of Coping and moderating Effect of Mindfulness. Acta Scientiarum Naturalium Universitatis Pekinensis. 2023;59(2):317–25. https://doi.org/10.13209/j.0479-8023.2023.005
doi: 10.13209/j.0479-8023.2023.005